Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1171 of 1,261
  1. US 6617110

    Cells immortalized with telomerase reverse transcriptase for use in drug screening

    The Regents of the University of Technology Office of Technology Transfer Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  2. US 6617350

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  3. US 6617331

    Purine inhibitors of protein kinases, G proteins and polymerases

    The Regents of the University of California Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  4. US 6617309

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  5. US 6617441

    Diagnostic test for borrelia infection

    The Board of Regents of the University of Texas Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  6. US 6617161

    Serum-free cell growth medium

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  7. US 6617122

    Process for identifying modulators of ABC1 activity

    Xenon Genetics Inc. Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  8. US 6617102

    Tankyrase H, compositions involved in the cell cycle and methods of use

    Rigel Pharmaceuticals, Inc. Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  9. US 6616925

    Combined preparation for the treatment of neoplasic diseases or of infectious diseases

    I.D.M. Immuno-Designed Molecules Β· Granted Sep 9, 2003 Β· Expires Sep 4, 2023

    expired
  10. US 6613764

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  11. US 6613883

    Screening assays for compounds that cause apoptosis and related compounds

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  12. US 6613792

    Treatment of premenstrual syndrome and menopause

    Designed Nutritional Products, Inc. Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  13. US 6613776

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  14. US 6613805

    Amine compounds, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  15. US 6613788

    Elevation of circulating blood histamine levels

    Maxim Pharmaceuticals, Inc. Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  16. US 6613761

    Benzoxazepine compounds, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  17. US 6613757

    COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY

    The Board of Regents of the University of Texas System Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  18. US 6613751

    Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation

    The Regents of the University of California Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  19. US 6613743

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  20. US 6613556

    Adaptation of virus to vertebrate cells

    The United States of America as represented by the Secretary of the Army Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  21. US 6613305

    Radionuclide labeling of vitamin B12 and coenzymes thereof

    Regents of the University of Minnesota Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  22. US 6613740

    Activity dependent neurotrophic factor III (ADNF III)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  23. US 6613739

    Deuterated cyclosporine analogs and their use as immunomodulating agents

    Isotechnika, Inc. Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired
  24. US 6613887

    Human ependymin-like protein

    Takeda Chemical Industries Ltd. Β· Granted Sep 2, 2003 Β· Expires Aug 28, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.